Categories
Glenmark Pharmaceuticals Limited — Updates, 18-05-2026: Press Release
18-05-2026 · 08:56 am
Glenmark Pharma's US subsidiary launched Vancomycin Hydrochloride for Injection, targeting a market with annual sales of approximately $37.9 million. This strengthens Glenmark's injectable portfolio and expands its US market presence.
No comments yet. Be the first to comment!